Achmea Investment Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Buy |
+34,193
| New | +$1.23M | 0.02% | 304 |
|
|
2023
Q3 | – | Sell |
-19,585
| Closed | -$602K | – | 608 |
|
|
2023
Q2 | $602K | Hold |
19,585
| – | – | 0.01% | 475 |
|
|
2023
Q1 | $705K | Sell |
19,585
-19,585
| -50% | -$705K | 0.02% | 426 |
|
|
2022
Q4 | $1.45M | Buy |
39,170
+19,585
| +100% | +$725K | 0.05% | 332 |
|
|
2022
Q3 | $787K | Buy |
19,585
+19,094
| +3,889% | +$767K | 0.03% | 429 |
|
|
2022
Q2 | $21K | Buy |
+491
| New | +$21K | ﹤0.01% | 596 |
|
|
2021
Q4 | – | Sell |
-491
| Closed | -$17K | – | 552 |
|
|
2021
Q3 | $17K | Buy |
+491
| New | +$17K | ﹤0.01% | 609 |
|
|
2021
Q2 | – | Sell |
-26,891
| Closed | -$1.17M | – | 509 |
|
|
2021
Q1 | $1.17M | Buy |
+26,891
| New | +$1.17M | 0.04% | 395 |
|